Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Cooper

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Artificial Intelligence in Medicine|February 1, 1997
An evaluation of machine-learning methods for predicting pneumonia mortalityG F Cooper, C F Aliferis, R Ambrosino, et al.
Molecular Genetics and Metabolism|February 28, 2012
Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C miceJennifer B Nietupski, Joshua J Pacheco, Wei-Lien Chuang, et al.
Plos One|July 9, 2011
Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff diseaseKaren M Ashe, Dinesh Bangari, Lingyun Li, et al.
Molecular Genetics and Metabolism|June 18, 2010
Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe diseaseKaren M Ashe, Kristin M Taylor, Qiuming Chu, et al.
Plos One|March 30, 2012
SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acidsPaul Mason, Beirong Liang, Lingyun Li, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Artificial Intelligence in Medicine|February 1, 1997
An evaluation of machine-learning methods for predicting pneumonia mortalityG F Cooper, C F Aliferis, R Ambrosino, et al.
Molecular Genetics and Metabolism|February 28, 2012
Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C miceJennifer B Nietupski, Joshua J Pacheco, Wei-Lien Chuang, et al.
Plos One|July 9, 2011
Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff diseaseKaren M Ashe, Dinesh Bangari, Lingyun Li, et al.
Molecular Genetics and Metabolism|June 18, 2010
Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe diseaseKaren M Ashe, Kristin M Taylor, Qiuming Chu, et al.
Plos One|March 30, 2012
SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acidsPaul Mason, Beirong Liang, Lingyun Li, et al.
Pageof 10